Each of the nine membrane-bound isoforms of adenylyl cyclase (AC) 1 catalyses formation of cAMP from ATP and each can be stimulated by the G protein, Gs, or (with the exception of AC-9) by forskolin (1, 2) . ACs are also regulated by many additional signals including protein kinases, other Gprotein subunits, nitric oxide, membrane potential and Ca 2+ (3) (4) (5) (6) . Because the isoforms differ in their regulation by these additional signals and each cell type expresses a different complement of AC isoforms, there is enormous potential for tailoring the cross-talk between AC and other signalling pathways to meet the specific needs of particular cell types. The effects of Ca 2+ on AC activity are particularly significant because they allow interplay between two of the most important and ubiquitously expressed intracellular signalling pathways (3, 7) . Four isoforms of AC are regulated directly by Ca 2+ : AC-1 and AC-8 are stimulated by Ca 2+ -calmodulin, while AC-5 and AC-6 are inhibited by Ca 2+ . In addition, some isoforms are regulated by enzymes that are themselves Ca 2+ -regulated: AC-9 is inhibited by Ca 2+ -calcineurin (8), 2 and AC-1 and AC-3 are inhibited by Ca 2+ -calmodulin-dependent protein kinases (CaMK) IV and II, respectively (1, 9 (10, 18) . This selective regulation of AC by CCE probably reflects the co-localization of some isoforms of AC and the Ca 2+ channels that mediate CCE in caveolae or lipid rafts (19) (20) (21) (22) . CCE is not, however, universally associated with regulation of AC. Ca 2+ entering via L-type Ca 2+ channels effectively inhibits AC in cardiac myocytes (23) and stimulates it in cerebellar granule cells (24) , although in GH 4 C1 cells such Ca 2+ signals are less effective than those evoked by CCE (18) .
Interactions between Ca 2+ and cyclic nucleotides are important in regulating the activities of many cell types (25, 26) . In smooth muscle, such interactions are major determinants of both contractile activity and proliferation (27) ] i -A7r5 cells grown (as above) in 96-well plates were loaded with fluo4 by incubation with fluo 4AM (2µM in fresh DMSO, final concentration 0.2%) and 0.2mg/ml Pluronic F-127 in HBS. After 1 hour at 20 o C, the cells were washed 3-times with HBS and then after 1 hour in HBS supplemented with 0.1% BSA (to allow complete hydrolysis of the indicator) the cells were again washed and used for experiments. For fluorescence measurements, the 96-well plate was mounted in a FlexStation (Molecular Devices), which allows up to three automated additions to each well. A Xelamp provided the excitation light and a scanning dual monochromator allowed control of excitation (485nm) and emission (525nm) wavelengths. Fluorescence was captured at 1-s intervals using SoftMaxPro software (Molecular Devices) and then averaged (over periods of 5s). At the end of each experiment, fluorescence of the Ca 2+ -saturated indicator (F max ) was determined for each well by addition of ionomycin (10µM) and CaCl 2 (final free concentration 10mM 
RESULTS AND DISCUSSION
Inhibition of AC by AVP requires activation of phospholipase C -In the presence of IBMX (1mM) to inhibit cyclic nucleotide phosphodiesterases, AVP, at concentrations (≤1µM, 5 mins) more than sufficient to maximally stimulate release of Ca 2+ from intracellular stores, had no effect on cAMP levels (Fig. 1A) . Under identical conditions, forskolin (5 mins) caused a concentration-dependent (half-maximal effective concentration, EC 50 ~12µM) stimulation of AC activity and this was inhibited by AVP (Fig. 1A) . A maximal concentration of AVP (1µM) caused 33 ± 2% (n = 3) inhibition of the response evoked by forskolin (100µM), and half-maximal inhibition (IC 50 ) occurred with 0.89 ± 0.22nM AVP (Fig. 1B) 1C) . In the absence of extracellular Ca 2+ , both the duration of the response and the maximal amplitude of the initial increase in [Ca 2+ ] i (1.69 ± 0.05µM versus 1.25 ± 0.09µM) were reduced (Fig. 1C) . The EC 50 for AVP-evoked Ca 2+ signals was similar in the presence (EC 50 = 14 ± 3nM) and absence (36 ± 25nM) of extracellular Ca 2+ (Fig. 1D ), but significantly higher than the IC 50 for inhibition of AC by AVP (Figs. 1B and 4A ). Neither component of the Ca 2+ response was affected by IBMX and forskolin (Fig. 1E ), or isoprenaline (not shown). This is important because it allows the effects of Ca 2+ on AC activity to be addressed without the complexity of cAMP affecting the Ca 2+ signals.
- Figure 1 Treatment of cells with pertussis toxin (100ng/ml for 24 hours) to uncouple the G-protein, Gi, from cell-surface receptors, had no effect on the ability of AVP to inhibit AC activity although it substantially reduced the effectiveness of carbamylcholine (CCh), an agonist of muscarinic acetylcholine receptors ( Fig.  2A) . We conclude, consistent with a previous report (33) , that inhibition of AC by AVP is not mediated by Gi or any other pertussis toxin-sensitive G protein.
- Figure 2 Inhibition of AC by AVP was completely inhibited by U73122 (10µM), a selective inhibitor of phospholipase C (45), though not by its inactive analogue, U73343 (Fig. 2B) . Nor did inhibitors of protein kinase C, GF 109203X (1µM, Fig. 2B ) or Ro 31-8220 (10µM, not shown), prevent AVP from inhibiting AC. Indeed, and consistent with earlier work suggesting that PKC tonically represses signalling from the AVP receptor (46, 47) , inhibition of PKC exaggerated the ability of AVP to inhibit AC. After pre-incubation with Ro 81-3220 (10µM, 5 mins), a maximal concentration of AVP inhibited forskolin-evoked AC activity by 57 ± 1% (n = 3, versus 35 ± 2% without inhibitor), although the sensitivity to AVP was unaltered (IC 50 = 0.6 ± 0.2nM).
We conclude that inhibition of AC by AVP requires activation of phospholipase C but not protein kinase C, despite the presence in A7r5 cells of AC-6 (33), which is known to be inhibited by PKC (48) . In subsequent experiments, we therefore examined the role of Ca 2+ in mediating the effects of AVP.
Sustained inhibition of AC by AVP requires an increase in cytosolic [Ca 2+ ] - Figure 3 shows the time course of cAMP accumulation in the presence of forskolin and IBMX alone or with AVP (100nM). As expected, cAMP continued to accumulate for at least 15 mins in the presence of forskolin. After 2-3 mins, the inhibitory effect of AVP had fully developed (~30% inhibition). Thereafter, and despite further stimulation of AC by forskolin, AVP maintained that 30% inhibition (Fig. 3) . The mechanism that links AVP to inhibition of AC therefore appears to take 2-3 mins to become maximally active, but then remains effective for at least 15 mins after AVP addition.
- Figure 3 Inhibition of forskolin-stimulated AC by AVP, measured during a 5-mins incubation, was unaffected by removal of extracellular Ca 2+ . Neither the maximal effect of AVP (52 ± 10% versus 48 ± 8% inhibition in the presence and absence of Ca 2+ , respectively) nor the sensitivity to AVP (IC 50 = 2.9 ± 1.9nM versus 1.2 ± 0.8nM) was affected by removal of extracellular Ca 2+ (Fig. 4A) .
In cells loaded with BAPTA-AM (50µM for 1 hour in Ca 2+ -free HBS) to buffer intracellular Ca 2+ , the Ca 2+ signal evoked by AVP was abolished (Fig. 4C) . Similar results were obtained when the intracellular stores were emptied by preincubation (15 mins in Ca 2+ -free HBS) with thapsigargin (1µM) or BHQ (10µM) to inhibit the endoplasmic reticulum Ca 2+ pumps. In each of these situations, AVP failed to inhibit AC activity, although inhibition of AC by CCh, mediated by Gi, was unaffected (Fig. 4B) 2+ channels was significantly smaller than that evoked by a maximal concentration of AVP (0.31 ± 0.03µM versus 1.7 ± 0.05µM), it was comparable to the response evoked by ~3nM AVP, which did inhibit AC (Figs. 1B,E) . Nevertheless, depolarization had no significant effect on AC activity, whether stimulated by forskolin or isoprenaline (Fig. 5B ). More importantly, neither nimodipine nor depolarization affected the inhibition of AC by AVP (Fig.  5B) ] i to increase to 588 ± 26nM and inhibited forskolin-evoked cAMP formation by 22 ± 3% (Fig. 6D) Figure 6E , suggest that the Ca 2+ signals provided by CCE activated by thapsigargin provide more effective inhibition of AC than the Ca 2+ signals evoked by AVP. At first sight, this observation appears to lend support to the idea that Ca 2+ signals evoked by CCE are preferentially coupled to inhibition of AC, as has been commonly observed in other cell types (7) . Subsequent experiments challenge this interpretation.
- Figure 6 -
AVP inhibition of AC is mediated by release of Ca
2+ from intracellular storesThe results so far indicate that both AVPevoked release of Ca 2+ from intracellular stores (Fig. 4A) and CCE (Fig. 6 ) can inhibit AC, although Ca 2+ entry via L-type channels appears to be relatively ineffective (Fig. 5B) . The lack of effect of Ca 2+ removal (Fig. 4A) , nimodipine or depolarization on inhibition of AC by AVP (Fig. 5) To address this issue, cells in normal HBS were stimulated with AVP; forskolin was then added for fixed periods of 5 mins, but beginning at different intervals after addition of AVP. Our aim was to assess whether the ability of AVP to inhibit AC was more effective during the initial phase of the response (when Ca 2+ release from intracellular stores predominates) or during the later phase (mediated by Ca 2+ entry). The surprising results demonstrate that irrespective of the presence of extracellular Ca 2+ , AVP (100nM) caused similar inhibition of AC whether its effects were assessed early or relatively late in the response (Fig. 7A) (Fig. 7B) . The key point is that in the absence of extracellular Ca 2+ , AVP maximally inhibited AC during a period (2-9 mins after AVP addition) when [Ca 2+ ] i had returned to its basal level (Fig. 7A) . This unexpected observation suggests that even though the AVP-evoked increase in [Ca 2+ ] i becomes entirely dependent on Ca 2+ entry after 1-2 mins (Figs. 1C, 7) , the effects of AVP on AC, while clearly requiring an increase in [Ca 2+ ] i (Fig. 4) , are independent of Ca 2+ entry. We therefore considered the possibility that the initial Ca 2+ signal resulting from release of Ca 2+ from intracellular stores might be responsible for a sustained inhibition of AC by AVP.
- (Fig. 8A) . These results are consistent with earlier work demonstrating that after rapid washout of AVP (and addition of the antagonist) the Ca 2+ signal reversed rapidly (t 1/2 ~20 s) (39) . We used this antagonist (in combination with AVP removal) to temporally separate activation of the V 1A -vasopressin receptor from the assessment of inhibition of AC. The method, depicted in Figure 8B , involves stimulating cells with AVP for 5 mins, and then activating AC (with forskolin) for a further 5 mins only after removal of AVP and addition of the vasopressin antagonist. The results establish that 5-mins incubation with AVP is sufficient, even when AVP is subsequently removed, to cause inhibition of AC comparable to that obtained in the continued presence of AVP (Fig. 8B ).
An analogous experiment with CCEmediated inhibition of AC is shown in Figure 8C . Cells were pretreated with thapsigargin in Ca 2+ -free HBS to empty intracellular stores, Ca 2+ was then restored to allow CCE to occur, and AC activity was then assessed by addition of forskolin either simultaneously with CCE or after a 2min period of CCE terminated by addition of extracellular BAPTA. The results demonstrate that although thapsigarginevoked CCE causes substantial inhibition of AC, the inhibition reverses as soon as the Ca 2+ signal terminates. These results suggest that it is the initial release of Ca 2+ from intracellular stores that is responsible for inhibition of AC by AVP, and that the inhibition persists for longer than the Ca 2+ signal that initiated it. By contrast inhibition of AC by CCE is acutely controlled by the intracellular free [Ca 2+ ].
- Figure 8 -A role for CaM kinase II -We and others (33) had supposed that inhibition of AC by Ca 2+ in A7r5 cells resulted from direct inhibition of AC (presumably AC-5 or AC-6) by Ca 2+ either competing with Mg 2+ at the ATP-binding site or by binding to a regulatory site on AC. But the long-lasting inhibition of AC by a transient IP 3 -evoked Ca 2+ signal is inconsistent with that idea. Our evidence that IP 3 -evoked release of Ca 2+ from intracellular stores effectively inhibits AC in A7r5 cells would also conflict with substantial evidence suggesting that AC-5 and AC-6 are preferentially inhibited by CCE (7) . Instead, we considered the possibility that AVP-mediated inhibition of AC in A7r5 cells might be mediated by AC-3, which though only weakly sensitive to Ca 2+ directly (10) is inhibited after phosphorylation at Ser-1076 by CaMKII (9) . KN-62 (10µM), a selective inhibitor of CaMKII, prevented the inhibition of AC by AVP, without affecting inhibition by CCh (Fig. 9A) , or the Ca 2+ signals evoked by maximal or submaximal concentrations of AVP (not shown) . KN-93 (1-10µM) , another inhibitor of CaMKII, proved not to be useful because it appeared directly to inhibit AC (not shown). We suggest that the ability of AVP to inhibit AC is mediated by Ca 2+ -activation of CaMKII.
- Figure 9 signal, and that phosphorylation of AC-3 by CaMKII is probably responsible. By contrast CCE, at least when activated by thaspigargin, can inhibit AC, but the inhibition persists only as long as the Ca 2+ signal. Previous work with arterial smooth muscle established that although it expressed several AC isoforms, prostaglandin E 2 stimulated only AC-3 and that such stimulation was essential for inhibition of cell proliferation (27) . This result highlights the likely importance of AC-3 in vascular smooth muscle, and its involvement in controlling a long-term response provides a satisfying link with our observation that transient Ca 2+ signals initiate a long-lasting inhibition of AC-3. Paradoxically, AVP has also been reported to potentiate Gs-mediated stimulation of AC in vascular smooth muscle and again the response appears to depend on Ca 2+ release from intracellular stores (36 Dyer et al., Fig. 1 B.
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